Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

2.41
-0.0200-0.82%
Volume:90.10K
Turnover:213.06K
Market Cap:12.38M
PE:-0.20
High:2.43
Open:2.43
Low:2.31
Close:2.43
Loading ...

CEL-SCI Corporation Applauds FDA Approval of Keytruda, Paving Way for Accelerated Multikine Regulatory Review

Reuters
·
18 Jun

CEL-SCI Corp - Multikine Reduced Risk of Death by 66% in Low Pd-L1 Patients

THOMSON REUTERS
·
18 Jun

FDA’s Approval of Keytruda for Pd-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in Pd-L1 Negative Cancer Patients

THOMSON REUTERS
·
18 Jun

BRF S.A. Meeting Postponed by CVM Decision

TIPRANKS
·
17 Jun

CEL-SCI Closes $5 Million Public Offering

MT Newswires Live
·
24 May

CEL-SCI Corporation Successfully Closes $5 Million Public Offering of Common Stock

Reuters
·
24 May

CEL-SCI Announces Closing of Public Offering

THOMSON REUTERS
·
24 May

Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views

Benzinga
·
22 May

Sector Update: Health Care Stocks Fall Premarket Thursday.

MT Newswires Live
·
22 May

CEL-SCI Prices Offering of 2 Million Shares

MT Newswires Live
·
22 May

BRIEF-Cel-Sci Says Prices Public Offering Of 2 Million Shares At $2.50 Per Share

Reuters
·
22 May

CEL-SCI Corporation Announces $5 Million Public Offering of Common Stock at $2.50 Per Share

Reuters
·
22 May

CEL-SCI Announces Pricing of Public Offering

THOMSON REUTERS
·
22 May

CEL-SCI Announces Planned Public Offering; Shares Fall After Hours

MT Newswires Live
·
22 May

CEL-SCI announces common stock offering, no amount given

TIPRANKS
·
22 May

CEL-SCI Completes Saudi Breakthrough Medicine Designation Application for Multikine Cancer Drug

MT Newswires Live
·
21 May

CEL-SCI Corporation Awaits Saudi SFDA's Decision on Breakthrough Medicine Designation for Multikine, Potentially Available by Summer 2025

Reuters
·
21 May

CEL-SCI Corporation Conducted Annual Shareholders Meeting

Reuters
·
20 May

CEL-SCI's Board Approves 1-for-30 Share Combination

MT Newswires Live
·
20 May

CEL-SCI expects 1 for 30 combination of common stock to be implemented on May 20

TIPRANKS
·
20 May